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Abstract
 
CD4
 
 
 
 T cell help is important for the generation of CD8
 
 
 
 T cell responses. We used depleting
anti-CD4 mAb to analyze the role of CD4
 
 
 
 T cells for memory CD8
 
 
 
 T cell responses after
secondary infection of mice with the intracellular bacterium 
 
Listeria monocytogenes
 
, or after
boost immunization by specific peptide or DNA vaccination. Surprisingly, anti-CD4 mAb
treatment during secondary CD8
 
 
 
 T cell responses markedly enlarged the population size of
antigen-specific CD8
 
 
 
 T cells. After boost immunization with peptide or DNA, this effect was
particularly profound, and antigen-specific CD8
 
 
 
 T cell populations were enlarged at least
10-fold. In terms of cytokine production and cytotoxicity, the enlarged CD8
 
 
 
 T cell popula-
tion consisted of functional effector T cells. In depletion and transfer experiments, the suppressive
function could be ascribed to CD4
 
 
 
CD25
 
 
 
 T cells. Our results demonstrate that CD4
 
 
 
 T cells
control the CD8
 
 
 
 T cell response in two directions. Initially, they promote the generation of a
CD8
 
 
 
 T cell responses and later they restrain the strength of the CD8
 
 
 
 T cell memory re-
sponse. Down-modulation of CD8
 
 
 
 T cell responses during infection could prevent harmful
consequences after eradication of the pathogen.
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Introduction
 
Infection of mice with 
 
Listeria monocytogenes
 
 causes a potent
CD8
 
 
 
 T cell response as an important component of pro-
tective immunity against this pathogen (1–3). In BALB/c
mice, a large fraction of CD8
 
 
 
 T cells is directed against
few dominant listerial proteins. The most dominant CD8
 
 
 
T cell epitope is listeriolysin O (LLO)
 
*
 
91–99
 
, a peptide de-
rived from the secreted protein listeriolysin (4, 5). At the
peak of the primary response, 3–4% of the CD8
 
 
 
 T cell
population are specific for LLO
 
91–99
 
, and during the sec-
ondary response, LLO
 
91–99
 
–specific T cells reach levels as
high as 15% of all CD8
 
 
 
 T cells (4). Listeriolysin has also
been used to vaccinate mice against 
 
L. monocytogenes
 
, and
we have recently demonstrated that repeated administration
of DNA containing hly, the gene encoding listeriolysin, in-
duces a LLO
 
91–99
 
–specific CD8
 
 
 
 T cell response and pro-
tects mice against subsequent 
 
L. monocytogenes
 
 infection (6).
Under various circumstances, priming of naive CD8
 
 
 
 T
cells requires signals from CD4
 
 
 
 T
 
H
 
 cells. However, CD4
 
 
 
T cell help is not essential and can be substituted by other
stimuli (7). A subpopulation of CD4
 
 
 
 T cells can also neg-
atively regulate immune responses (8, 9). These regulatory
or suppressor T cells are CD4
 
 
 
D25
 
 
 
 and are enriched in
the CD45RB
 
low
 
 T cell population. The mode of action of
these T cells is still unclear and may include direct mecha-
nisms via cell–cell contact or the production of inhibitory
cytokines such as IL-10 or TGF-
 
 
 
 (8, 9). Although regula-
tory T cells have been demonstrated in several autoimmune
models, there is only limited evidence for a function of
these cells during infection or vaccination. Particularly,
their role in the regulation of CD8
 
 
 
 T cell responses is
largely unknown (8, 9).
Here we analyzed the role of CD4
 
 
 
 T cells in the forma-
tion of memory CD8
 
 
 
 T cell responses after secondary 
 
L.
monocytogenes
 
 infection, or after boost immunization with
the peptide LLO
 
91–99
 
 or a DNA vaccine containing the
gene for listeriolysin. Depletion of CD4
 
 
 
 T cells signifi-
cantly enhanced memory CD8
 
 
 
 T cell responses, particu-
larly after peptide and DNA immunization. Further deple-
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tion and transfer experiments demonstrated that the
suppressive activity was enriched in the CD4
 
 
 
CD25
 
 
 
 T
cell population. Thus, CD4
 
 
 
 T cells regulate a CD8
 
 
 
 T
cell response in both directions. During primary responses,
CD4
 
 
 
 T cells promote the generation and accumulation
of specific CD8
 
 
 
 T cells, during memory responses,
CD4
 
 
 
CD25
 
 
 
 T cells restrict the strength of the response.
 
Materials and Methods
 
Bacterial Infection of Mice.
 
BALB/c mice and SCID mice were
bred in our facility at the Federal Institute for Health Protection
of Consumers and Veterinary Medicine in Berlin, and experi-
ments were conducted according to the German animal protec-
tion law. Mice were infected with 
 
L. monocytogenes
 
 strain EGD.
For primary infection, mice received 2 
 
 
 
 10
 
3
 
 bacteria intrave-
nously. After 8–12 wk, mice were secondary infected with 10
 
5
 
bacteria intravenously (10).
 
Antibodies.
 
Rat Ig, anti-CD16/CD32 mAb (2.4G2), anti-
CD8
 
 
 
 mAb (YTS169), anti-CD4 mAbs (YTS191.1 and GK1.5),
anti-CD25 mAb (PC61), anti-CD62L mAb (Mel-14), anti-
CD152/CTL-associated antigen (CTLA-4) mAb (9H10), anti–
IFN-
 
 
 
 mAb (clone: R4–6A2, IgG1), and anti–TGF-
 
 
 
 mAb
(2G7) were purified from rat serum or hybridoma supernatants
with protein G sepharose. Antibodies were Cy5- or FITC-conju-
gated according to standard protocols. FITC-conjugated anti-
CD25 mAb (7D4), PE-conjugated anti–TNF-
 
 
 
 mAb (MP6-
XT22, IgG1), and FITC- and PE-conjugated rat-IgG1 isotype
control mAb (R3–34) were purchased from BD Biosciences.
 
DNA and Peptide Immunization.
 
The plasmid pChly was con-
structed by cloning the hly (listeriolysin) gene into the eukaryotic
expression plasmid pCI (6). The plasmid pCMV-GM-CSF con-
tains the gene encoding GM-CSF under the control of a CMV
promoter. DNA of pChly (1.0 
 
 
 
g) was coprecipitated with 0.8
 
 
 
g of pCMV-GM-CSF on 1.0-
 
 
 
m gold particles (0.5 mg).
Phosphothiate-modified oligodeoxynucleotides (ODN) contain-
ing a CpG motif (ODN1760; reference 11) were synthesized by
Interactiva Biotechnology. For gene gun immunization, two
nonoverlapping shots per mouse were performed into freshly
shaven abdominal skin using 0.5 mg DNA-coated gold particles
per shot. Subsequently, 10 
 
 
 
g of the CpG-containing ODN were
injected intradermally at the site of particle bombardment (6).
The peptide LL0
 
91–99
 
 (GYKDGNEYI; Jerini Bio Tools) was
dissolved at 2 mg/ml in PBS. The solution was emulsified with
an equal volume of Freund’s incomplete adjuvant. Mice were in-
jected subcutaneously with 100 
 
 
 
l of the emulsion corresponding
to 100 
 
 
 
g of peptide.
 
In Vivo mAb Applications.
 
CD4
 
 
 
 T cells were depleted by in-
traperitoneal injection of 300 
 
 
 
g of anti-CD4 mAb (YTS191.1)
at intervals of 5 d starting 3 d before infection or immunization.
Efficacy of depletion was 
 
 
 
95%. CD25
 
 
 
 cells were depleted by
intraperitoneal injection of 250 
 
 
 
g of anti-CD25 mAb (PC61) at
days 
 
 
 
5, 
 
 
 
1, 2, and 4 of immunization (efficacy: 
 
 
 
75%).
CTLA-4 and TGF-
 
 
 
 were blocked by daily intraperitoneal injec-
tion of 250 
 
 
 
g of anti-CD152 mAb or 500 
 
 
 
g of anti–TGF-
 
 
 
mAb, respectively, starting at the day of immunization.
 
Purification of Cells and Reconstitution of SCID Mice.
 
Spleno-
cytes from naive mice or mice infected 3 mo earlier with 
 
L. mono-
cytogenes
 
 were incubated with biotinylated anti-CD25 mAb and
magnetic anti-biotin micro beads (Miltenyi Biotec), and CD25
 
 
 
T cells were purified with a magnetic column (autoMACS;
Miltenyi Biotec). T cells bound and recovered from the column
 
were 
 
 
 
75% CD25
 
 
 
 and 
 
 
 
90% CD4
 
 
 
. CD25-depleted cells were
incubated with FITC-conjugated anti-CD4 mAb (GK1.5) and
subsequently with anti–FITC-mAb–coated magnetic micro beads
(Miltenyi Biotec). CD4
 
 
 
 T cells were isolated using the au-
toMACS and were 
 
 
 
98% CD4
 
 
 
 and 
 
 
 
0.5% CD25
 
 
 
.
BALB/c mice were immunized with pChly DNA, and after 7
wk, mice were CD4 T cell depleted by intraperitoneal adminis-
tration of 300 
 
 
 
g anti-CD4 mAb (depletion efficiency: 
 
 
 
95%). 3 d
later, mice were killed, and splenocytes were adoptively trans-
ferred into SCID mice (40 
 
 
 
 10
 
6
 
/mouse, intravenously). SCID
mice received in addition purified CD4
 
 
 
CD25
 
 
 
 T cells (12  
106) or CD4 CD25  T cells (4   106) from naive or listeria-
infected mice. Immediately after cell transfer, mice were immu-
nized with pChly DNA. Mice were analyzed 7 d after cell trans-
fer and immunization.
Cytotoxicity Assay. Spleen cells were incubated with 5,000
51Cr-labeled P815 target cells at the effector/target ratios indi-
cated. Peptides were added at 10 6 M. After 4 h, supernatants
were counted with a  -counter. Each value was determined as
triplicate (10). Cytotoxicity is given as percent specific lysis which
was calculated with the formula: percent specific lysis   100  
(experimental  51Cr-release    spontaneous 51Cr-release)/(deter-
gent induced 51Cr-release   spontaneous 51Cr-release)
Tetramer Staining and Flow Cytometric Determination of Cytokine
Expression. Intracellular cytokine staining after short term in
vitro restimulation was performed as described (10). Briefly,
spleen cells were stimulated for 5 h with 10 6 M of the peptide
LLO91–99. During the final 4 h of culture, 10  g/ml Brefeldin A
(Sigma-Aldrich) were added. Cultured cells were extracellularly
stained with Cy5-conjugated anti-CD8  mAb, and intracellu-
larly stained with FITC-conjugated anti–IFN-  mAb and PE-
conjugated anti-TNF-  mAb or FITC- and PE-conjugated iso-
type control mAb. Cells were analyzed using a FACSCalibur™
and the CELLQuest™ software (Becton Dickinson).
Generation of LLO91–99/H-2Kd-tetramers and analysis of cells
with tetramers has been described previously (10).
Statistical Analysis. Statistical significance of results was deter-
mined using the unpaired Student’s t test. *P   0.05; **P   0.01.
Results
CD8  T Cell Responses during Primary and Secondary Infec-
tion with L. monocytogenes in CD4  T Cell–depleted Mice.
Infection of mice with L. monocytogenes causes a strong
CD8  T cell response that is crucial for protective immu-
nity. There is also a strong induction of a CD4  T cell re-
sponse during L. monocytogenes infection, but the relevance
of these cells during infection is less clear (2, 3). An impor-
tant function of CD4  T cells is to provide help for the
generation of CD8  T cell responses. To analyze this func-
tion in more detail, BALB/c mice were treated with a de-
pleting anti-CD4 mAb and infected with L. monocytogenes.
The CD8  T cell response was analyzed with MHC class I
tetramers containing the immunodominant CD8  T cell
epitope LLO91–99 (4, 10). During primary infection, deple-
tion of CD4  T cells caused an  50% reduction of the fre-
quency of LLO91–99–specific CD8  T cells in spleens of in-
fected mice (Fig. 1 A). Surprisingly, depletion of CD4  T
cells during secondary infection did not diminish, but in-
creased frequencies and numbers of listeria-specific CD8 
T cells (Fig. 1 B, and unpublished data). During both pri-1587 Kursar et al.
mary and secondary infection, neither the bacterial titers in
spleen and liver nor the course of bacterial clearance were
significantly altered by anti-CD4 mAb treatment (unpub-
lished data).
CD4  T Cell Depletion Enhances Memory CD8  T Cell
Responses after Peptide or DNA Immunization. Protection
against secondary listeriosis is predominantly mediated by
CD8  T cells, but CD4  T cells participate as well in the
response against L. monocytogenes (3). Thus, the lack of liste-
ria-specific CD4  T cells could result in higher bacterial ti-
ters and delayed bacterial clearance. Consequently, the en-
hanced CD8  T cell response could be due to an increase
in antigen load. Although we did not observe a significant
difference in bacterial titers during secondary infection be-
tween control mice and anti-CD4 mAb-treated mice, we
cannot formally exclude that the enhanced CD8  T cell
response reflects compensatory mechanisms. To circum-
vent this problem, mice were infected with L. monocytoge-
nes, and secondary CD8  T cell responses were analyzed
following specific DNA or peptide immunization. For
DNA immunization, the plasmid pChly containing the
gene for listeriolysin (hly) under the control of a eukaryotic
promoter was applied with a gene gun (6). The peptide
LLO91–99 was given subcutaneously in incomplete Freund’s
adjuvant (Fig. 2). Prior to treatment, LLO91–99–specific
CD8  T cells comprised 0.1–0.2% of CD8  T cells. Both
DNA and peptide immunization increased frequencies of
LLO91–99–specific CD8  T cells. Depletion of CD4  T
cells drastically enlarged the frequencies and numbers of
these T cells. In all experiments, CD4  T cell depletion
caused at least a 10- to 20-fold enhancement of the LLO91–99–
specific CD8  T cell response (Fig. 2, and unpublished
data). DNA immunization was also used to analyze the ef-
fect of CD4  T cell depletion in a setting independent
from infection. Mice were prime/boost immunized with
pChly DNA. 50 d after priming, frequencies of LLO91–99
specific-CD8  T cells were close to the detection levels of
the tetramer assay (unpublished data and Table I). Boost
with the same DNA construct resulted in frequencies of
 1.5% at day 7 after immunization. Depletion of CD4  T
cells during the boost markedly enhanced frequencies (up
to 40%) and numbers of LLO91–99–specific CD8  T cells
(Figs. 3 A and 4 A).
In contrast to the strong effect of anti-CD4 mAb treat-
ment on the memory response after secondary DNA or
peptide immunization, this treatment had only limited
consequences after primary immunization. With both im-
munization protocols, we obtained only very low frequen-
cies of LLO91–99–specific CD8  T cells after a single immu-
nization. 9 d after a primary immunization, frequencies
were close to the detection limit of our assays (0.05–0.10%
LLO91–99-tetramer CD62Llow cells or IFN- –producing
cells of CD8  spleen cells). Anti-CD4 mAb treatment did
not significantly alter these responses (unpublished data).
A lymphopenic environment can induce homeostatic T
cell proliferation in the absence of antigen stimulation (12).
To analyze whether the expansion of the antigen-specific
CD8  T cell population was due to a homeostatic prolifer-
ation after CD4  T cell depletion, mice were either in-
fected or DNA immunized, and after 2 mo treated with
anti-CD4 mAb without any further challenge. 10 d after
anti-CD4 mAb injection, mice were analyzed (Table I). At
this time point, frequencies and numbers of memory CD8 
T cells were close to the detection level of our assays. 2 mo
Figure 1. LLO91–99–specific
CD8  T cell response during
primary and secondary infection
with  L. monocytogenes (A) Pri-
mary infection: mice infected
with  L. monocytogenes were left
untreated (control) or received
anti-CD4 mAb (anti-CD4). (B)
Secondary infection: mice were
infected and after 60 d chal-
lenged with L. monocytogenes.
During challenge infection, mice
were left untreated or received
anti-CD4 mAb. At the indicated
days, spleen cells were stained
with Cy5-conjugated anti-
CD8  mAb, FITC-conjugated
anti-CD62L mAb, and PE-
labeled LLO91–99-tetramers, and
analyzed by flow cytometry af-
ter the addition of propidium io-
dide. Figures show percent val-
ues of live CD62Llowtetramer  cells of total CD8  cells. Data represent
mean   SD of three mice per group and time point. Experiments in A
and B are representative of two or three experiments, respectively.
Figure 2. Response against peptide and DNA boost-immunization of
L. monocytogenes–primed mice after CD4  T cell depletion. Mice were in-
fected with L. monocytogenes. After 100 d, mice were immunized either
with the peptide LLO91–99 in incomplete Freund’s adjuvant subcutane-
ously or with pChly DNA using the gene gun. Groups of mice were left
untreated (control) or were injected with anti-CD4 mAb during the boost
immunization. On day 7, spleen cells were stained and analyzed by flow
cytometry. Dot plots depict CD62L and LLO91–99-tetramer staining of vi-
able CD8  gated cells. The experiment shown is representative of two in-
dependent experiments with three individually analyzed mice per group.1588 CD4 CD25  T Cells Regulate Memory CD8  T Cell Responses
after both L. monocytogenes infection and DNA immuniza-
tion, anti-CD4 mAb treatment did not induce a significant
expansion of the LLO91–99–specific CD8  T cell popula-
tion. This result indicates that in our experimental model
the expansion of the specific memory CD8  T cell popula-
tion after CD4  T cell depletion depended on antigen
challenge and was not due to homeostatic proliferation. In
accordance with this result is the observation that, in con-
trast to the strong enhancement of the memory CD8  T
cell response following CD4  T cell depletion, the total
CD8  T cell population is not enlarged significantly (un-
published data).
CD8  T Cells Activated in the Absence of CD4  T Cells
Are Functional Effector Cells. To determine whether the
enlarged LLO91–99–specific CD8  T cell population after
CD4  T cell depletion consisted of functional CD8  effec-
tor T cells, mice were primed and boosted with a DNA
vaccine. During boost immunization, mice were treated
with anti-CD4 mAb. After 7 d, spleen cells were either
stained with tetramers (Fig. 3 A) or restimulated in vitro for
5 h with the peptide LLO91–99, and analyzed for IFN-  and
TNF-  production (Fig. 3 B). Frequencies of LLO91–99-
tetramer  T cells and of cytokine producing CD8  T cells
were similar after CD4  T cell depletion. In addition, cells
were isolated and directly incubated for 4 h with LLO91–99–
loaded target cells in a 51Cr-release assay (Fig. 3 C). Anti-
gen-specific cytotoxicity was only detected in cells from
anti-CD4 mAb-treated mice. In contrast to the tetramer
and intracellular cytokine staining, the cytotoxicity assay
does not provide information on activities of individual
cells. Therefore, we cannot make any statement on cyto-
toxic functions of individual cells, yet our experiments
demonstrate that after in vivo antigen restimulation, anti-
CD4 mAb treated mice contain a population of cells with
specific cytotoxic capabilities. Hence, LLO91–99–specific
CD8  T cells generated in absence of CD4  T cells were
Table I. Anti-CD4 mAb Treatment Does Not Induce
LLO91–99–specific CD8  Memory T Cell Proliferation in the Absence 
of Antigen Stimulation
Percent
LLO91–99-tetramer 
of CD8  cells
LLO91–99-tetramer CD8 
cells/spleen
Naive  0.02  1,000
  anti-CD4 mAb  0.02  1,000
L. monocytogenes 0.06   0.01 1,700   100
  anti-CD4 mAb 0.07   0.04 2,700   1,600
Gene gun 0.09   0.04 3,900   2,800
  anti-CD4 mAb 0.10   0.03 3,400   900
Mice were infected with L. monocytogenes or immunized with pChly
DNA using the gene gun. After 2 mo, mice were treated with anti-CD4
mAb or were left untreated. Injection of anti-CD4 mAb was repeated
after 5 d, and 10 d after the first mAb injection mice were killed, spleen
cells were counted, stained with anti-CD8 mAb, anti-CD62L mAb, and
LLO91–99-tetramers, and analyzed by flow cytometry. Since in the
spleen, a subpopulation of memory CD8  T cells reacquires CD62L
expression, results are given for total CD8  T cells (CD62Llow and
CD62Lhigh). Data represent mean   SD of three mice per group. The
experiment shown is representative for two individual experiments with
similar results.
Figure 3. Effector functions of LLO91–99–specific CD8  T cells after
prime/boost DNA immunization. Mice were immunized with pChly us-
ing the gene gun. After 50 d, a boost immunization with the same DNA
was performed. Mice were left untreated (control) or were treated with
anti-CD4 mAb during the boost immunization. At day 7, mice were
killed. (A) Spleen cells were stained and analyzed by flow cytometry. Dot
plots depict CD62L and LLO91–99-tetramer staining of viable CD8-gated T
cells and figures represent percent values calculated for CD8  T cells only.
(B) Spleen cells were cultured for 5 h with or without the peptide LLO91–99
and stained extracellularly for CD8 and intracellularly for IFN-  and
TNF-  or with isotype control mAbs. Dot blots show CD8-gated cells,
and figures give percent values calculated for CD8  T cells only. Values for
isotype controls were below 0.05% (data not depicted). Dot blots in A and
B show corresponding results from the same mice. (C) Spleen cells from
untreated (diamonds) or anti-CD4 mAb-treated mice (triangles) were in-
cubated for 4 h with target cells with (filled symbols) or without LLO91–99
(open symbols). After 4 h, lysis of target cells was determined. C shows re-
sults from three individually analyzed mice per group. Experiments in A–C
are representative for at least two independent experiments with three indi-
vidually analyzed mice per experimental group in each experiment.1589 Kursar et al.
functional effector cells in terms of IFN-  and TNF-  se-
cretion, and at least a subpopulation of these cells expresses
specific cytotoxicity.
Inhibition of Memory CD8  T Cell Responses by CD25 
Cells. Increasing evidence suggests that a subpopulation
of CD4  T cells can suppress immune responses (8, 9). Al-
though a distinct surface phenotype of regulatory T cells
has not been defined as yet, these cells are enriched in the
CD4 CD25  T cell population (8, 9). Regulatory T cells
are further associated with the expression of CTLA-4/
CD152 and TGF-  (13–16). Mice were primed and
boosted by DNA immunization, and the role of different
cell populations and molecules during the secondary CD8 
T cell response was analyzed by administration of antibod-
ies that either deplete positive cell populations or block the
function of the recognized proteins (Fig. 4). Depletion of
CD25  T cells markedly enhanced the numbers of LLO91–99-
tetramer–reactive CD8  T cells and of CD8  T cells re-
sponding to LLO91–99 stimulation with IFN-  production,
although this increase was less pronounced as compared
with that after anti-CD4 mAb treatment. In contrast, mAbs
against CD152 or TGF-  did not significantly alter the sec-
ondary CD8  T cell response (Fig. 4).
Inhibition of Memory CD8  T Cell Responses by CD4 
CD25  Cells in a Transfer Model. So far, our assumption
that CD4 CD25  T cells suppress CD8  memory T cell
responses is based on antibody depletion experiments. How-
ever, antibody treatment, particularly anti-CD4 mAb treat-
ment, could have effects beyond CD4  T cell depletion,
which we cannot fully exclude. Therefore, we assessed the
role of CD4 CD25  T cells for memory CD8  T cell re-
sponses in SCID mice that were immunized after reconsti-
tution with defined T cell populations. SCID mice re-
ceived CD4-depleted cells from mice that had been DNA
immunized 5 wk earlier. Groups of these mice received
purified CD25  T cells ( 90% CD4 ) or purified
CD4 CD25  T cells in addition. Purified T cells were de-
rived either from naive mice, or from mice that had been
infected with L. monocytogenes 3 mo before transfer. After
reconstitution, SCID mice were DNA immunized. 7 d
later, LLO91–99-tetramer–reactive T cells and IFN-  pro-
duction after LLO91–99 stimulation were determined (Fig.
5). In SCID mice reconstituted with CD4-depleted cells
from previously immunized mice, DNA immunization
caused strong proliferation of LLO91–99–specific CD8  T
cells. Addition of CD4 CD25  T cells from either naive
or L. monocytogenes infected mice did not significantly alter
expansion of these CD8  T cell populations. In contrast,
cotransfer of CD4 CD25  T cells markedly impaired the
LLO91–99–specific CD8  T cell response, and this inhibi-
Figure 4. Inhibition of memory CD8  T cell responses by CD4  and
CD25  cells BALB/c mice were immunized with pChly using the gene
gun, and after 35 d, a boost immunization with the same DNA was per-
formed. During boost immunization, mice were treated with purified rat
Ig or the mAb indicated. On day 7, spleen cells were analyzed with
LLO91–99-tetramers (A) and for IFN-  production after incubation with
LLO91–99 (B), as described in Fig. 3. Without peptide stimulation, we ob-
served  4,000 IFN-  CD8  T cells/spleen in all samples analyzed (data
not depicted). The experiment shown is representative of three similar
experiments and represents mean   SD of three individually analyzed
mice per group. Differences to rat Ig treatment: *P   0.05; **P   0.01;
NS, P   0.05.
Figure 5. Inhibition of memory CD8  T cell responses by
CD4 CD25  cells in a transfer model SCID mice received CD4-depleted
cells from mice previously immunized by DNA vaccination. Groups of
mice received in addition purified CD4 CD25  and CD4 CD25  cells
from either naive or L. monocytogenes–infected mice. Immediately after
cell transfer, mice were DNA immunized with pChly. On day 7, spleen
cells were analyzed with LLO91–99-tetramers (A) and for IFN-  produc-
tion after incubation with LLO91–99 (B), as described in Fig. 3. Without
peptide stimulation we observed  1,500 IFN-  CD8  T cells/spleen in
all samples analyzed (data not depicted). The experiment shown repre-
sents mean   SD of three individually analyzed mice per group and is
representative for three independent experiments. Differences to gene
gun treated mice that received only CD4  T cell–depleted cells: *P  
0.05; **P   0.01; NS, P   0.05.1590 CD4 CD25  T Cells Regulate Memory CD8  T Cell Responses
tion was observed with CD4 CD25  T cells derived from
both naive and L. monocytogenes–infected mice.
Discussion
CD4  T cells supported but were not essential for the
generation of specific CD8  T cells in experimental listeri-
osis of mice. TH cell–independent generation of CD8  T
cell responses has been described before, and it has been
suggested that signals associated with infection or inflam-
mation can bypass the need for CD4  T cell help (7, 17).
L. monocytogenes infection causes a strong inflammation in
spleen and liver. It is, therefore, not unexpected that the
absence of CD4  TH cells causes only a minor impairment
of the CD8  T cell response in this model.
Depletion of CD4  T cells during the secondary anti-
listeria response did not impair the specific CD8  T cell re-
sponse, which is consistent with less restricted activation
requirements of memory T cells. Rather, depletion of
CD4  T cells enlarged the specific CD8  T cell population
indicating that CD4  T cells inhibited the secondary
CD8  T cell response. As it has been demonstrated that
CD4  T cells contribute to protection against L. monocy-
togenes (3), we cannot formally exclude that the enhanced
CD8  T cell response in anti-CD4 mAb-treated mice was
caused by compensatory mechanisms. However, the en-
hanced response in the absence of CD4  T cells was even
more pronounced when memory CD8  T cell responses
were induced by specific peptide or DNA immunization.
These conditions virtually exclude differences in antigen
load and persistence, or strength of inflammation, and
strongly imply suppression of memory CD8  T cell re-
sponses by CD4  T cells.
In various autoimmune models, T cells with suppressive
functions are highly enriched in the CD4 CD25  T cell
population (8, 9). Our depletion and transfer experiments
are consistent with these observations. Depletion of
CD25  cells enhanced the secondary CD8  T cell re-
sponse, and reciprocally, adoptive transfer of CD25  T
cells inhibited the response. Compared with the anti-CD4
mAb treatment, the anti-CD25 mAb treatment was less ef-
ficient, whereas adoptive transfer of suppression was only
achieved with CD25  T cells. Incomplete depletion of
CD25  T cells in anti-CD25 mAb treated mice could ex-
plain this discrepancy (we achieved  75% depletion of
CD25  cells compared with  95% depletion of CD4 
cells). As CD8  T cells up-regulate CD25 expression upon
activation, it is also possible that the anti-CD25 mAb-treat-
ment directly affected the LLO91–99–specific CD8  T cell
population. However, an enlarged memory CD8  T cell
response was also observed when the anti-CD25 mAb was
applied before the boost immunization (unpublished data).
Finally, although there is a concentration of the suppressive
function in the CD4 CD25  cell population during trans-
fer experiments, we cannot exclude an additional subset of
regulatory T cells amongst the CD4 CD25  T cell popu-
lation, as has been described before (9, 18). Regulatory T
cells have been associated with the expression of CD152/
CTLA-4, and membrane bound or secreted TGF- , and
TGF-  is a potential mediator of suppression (13–16). In
our system, treatment of mice with blocking anti-CD152
mAb or anti–TGF-  mAb did not alter memory CD8  T
cell responses. As we applied both mAb in doses that have
been proven effective in other experimental models analyz-
ing suppressive T cells (19, 20), we can largely exclude ab-
sence of response due to inadequate experimental proce-
dures. Our results, therefore, indicate a mode of action for
regulatory CD4 CD25  T cells that, in our model, is
largely independent from CTLA-4 and TGF- .
Transfer of T cells into lymphopenic mice induces anti-
gen-independent homeostatic proliferation of these cells
(12). It is therefore possible that a similar induction of pro-
liferation might occur in LLO91–99–specific memory CD8
T cells in our assays. However, we did not observe signifi-
cant expansion of the specific memory CD8  T cell popu-
lation after CD4  T cell depletion without antigen stimu-
lation. Furthermore, there was no expansion of this cell
population after transfer into SCID mice unless these mice
were DNA immunized. These results strongly argue for a
direct suppressive function of CD4  T cells on the mem-
ory CD8  T cell response and against homeostatic pro-
cesses, although we cannot exclude a low rate of homeo-
static proliferation of the analyzed memory CD8  T cell
population, which might be below the detection level of
our assays. More recently, Murakami et al. demonstrated
the involvement of CD25 CD4  T cells in the control of
CD8  memory T cell homeostasis (21). In the experiments
described, memory CD8  T cells were defined by the
CD44highIL-2R high surface phenotype and not by the ex-
pression of a TCR involved in a prior immune response
(21). The different cell populations analyzed in their and in
our study could explain the controversial results.
The mechanisms that activate regulatory T cells, and the
antigens recognized by these cells remain unknown (22). In
our experiments, memory CD8  T cells were activated by
a DNA vaccine encoding the gene for listeriolysin, or the
peptide LLO91–99. Listeriolysin harbors only negligible
CD4  T cell epitopes for BALB/c mice (5), and it is highly
unlikely that the 9-mer peptide LLO91–99 is recognized by
CD4  T cells. Therefore, we assume that the antigens rec-
ognized by regulatory T cells and by the regulated T cells
are unrelated. Consistent with this assumption, CD25  T
cells from naive and L. monocytogenes–infected mice exhib-
ited similar suppression in the adoptive transfer model.
Regulatory T cells have been shown to suppress activa-
tion of CD8  T cells in vitro (23). In these studies, sup-
pression affected proliferation and IFN-  production of
CD8  T cells and was independent of the antigen recog-
nized by the CD8  T cells. In different tumor models, de-
pletion of CD4  T cells has been shown to enhance CD8 
T cell–mediated tumor rejection (24, 25). Gunn et al.
demonstrated that CD4  T cell depletion improved tumor
rejection after therapeutic tumor vaccination (19). Rejec-
tion was also enhanced following anti–TGF-  mAb and
anti-CD25 mAb treatment. In a different therapeutic tu-1591 Kursar et al.
mor vaccination model, depletion of CD4  T cells en-
hanced the efficacy of the vaccine (20). Anti-CD25 mAb
treatment alone only slightly improved vaccine efficacy,
but anti-CD25 mAb and anti–CTLA-4 mAb synergized in
promoting tumor rejection accompanied by enhanced fre-
quencies of tumor reactive CD8  T cells. Although these
studies demonstrate that priming and effector functions of
CD8  T cells are regulated by CD4  T cells, regulation of
memory responses was not addressed in these studies (19,
20). To our knowledge our results describe for the first
time control of memory CD8  T cell responses by regula-
tory CD4  T cells in vivo.
In summary, our results reveal that CD4  T cells sub-
stantially suppress CD8  memory T cell responses. This
phenomenon was particularly obvious after secondary
DNA and peptide immunization and weakly evident dur-
ing secondary L. monocytogenes infection. DNA and peptide
immunization are relatively weak stimulators of CD8  T
cell responses. In contrast, L. monocytogenes induces a strong
CD8  T cell response and is accompanied by inflammation
of the infected organs. Therefore, the CD8  T cell re-
sponse after L. monocytogenes infection should be less recep-
tive to restrictions by suppressive CD4  T cells than the re-
sponse to DNA or peptide immunization. Furthermore,
enhanced proliferation of CD8  T cells in the absence of
CD4  T cells depended on antigen stimulation. The clear-
ance of L. monocytogenes after secondary infection but also
of peptide or DNA vaccine–induced proteins is, therefore,
still a limiting factor for the CD8  memory T cell response.
The situation should be different for repeated or chronic
infections. Lack of counter-regulation could cause exagger-
ated CD8  T cell responses with severe consequences such
as immunopathology or paralysis of the immune system.
Thus, control of secondary CD8  T cell responses by
CD4  T cells has to be considered an important element of
the immune response after infection or vaccination.
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